Alicon Q1 FY27: consolidated PAT +23% YoY on paper, EBITDA margin compression misses guide
PAT +22.89% YoY · revenue +37.91% · margins compressing
₹578.01 Cr
+37.91% YoY
₹11.45 Cr
+22.89% YoY
1.98%
-0.1pp YoY
₹7.02
Consolidated revenue rose 37.9% YoY (₹578.0 Cr vs ₹419.1 Cr) and 16.8% QoQ, with consolidated PAT of ₹11.45 Cr (EPS ₹7.02), up 22.9% YoY and 44.2% QoQ off a weak Q4 FY26 base (₹7.94 Cr). But the Jun-25 base carried a ₹2.57 Cr one-off legal-settlement expense that this quarter lacks; stripping that out, adjusted YoY PAT growth is only ~2%, effectively flat. Standalone tells a much stronger story — PAT ₹17.66 Cr (EPS ₹10.82), up ~97% YoY reported / ~62% adjusted — because the European step-down subsidiaries are a drag on the group number; that basis gap (>50pp on adjusted growth) is unusually wide.
Q1 FY-2027 vs prior quarters
Management's FY27 concall guidance called for 8-10% revenue growth excluding aluminum price effects, 20%+ absolute EBITDA growth and ~1.5pp margin expansion. Consolidated EBITDA (revenue − costs ex finance/depreciation) grew only ~11% YoY to ₹54.24 Cr, and OPM compressed to 9.38% from ~11.7% a year ago — the opposite of the guided expansion — while the reported 37.9% topline growth, far above the ex-aluminum 8-10% band, points to aluminum price pass-through rather than volume-led growth. NPM held roughly flat YoY at 1.98% vs 2.22%. No analyst consensus estimates for this quarter were found in a web search, so vsStreet is unknown; no management press commentary was available to cross-check against the numbers.
The stock went into the print at ₹741.35, up 16.6% over the past month of trading.
For context: PAT has now risen for 2 consecutive quarters.
Management guides for a modest 8-10% revenue growth in FY27, excluding aluminum price volatility, but expects a more significant 20%+ growth in absolute EBITDA, implying a margin expansion of approximately 1.5%. This will be supported by a capex of ₹130-150 crore, funded by internal accruals, primarily for capacity exp
— This quarter: missed
On the corporate side, the board recommended a ₹3/share final dividend (60%) for FY25-26, taking the full-year payout to ₹5/share (100%) alongside the July 31 announcement of a new ₹125.5 Cr (₹1,255 Mn) die-casting plant — consistent with the guided ₹130-150 Cr FY27 capex for capacity expansion and automation. Next quarter's watch is whether EBITDA growth and margin catch up to the guided trajectory, and whether the European subsidiary drag narrows.
W1
EBITDA growth trajectory — management guided 20%+ FY27 growth with ~1.5pp margin expansion; Q1 delivered only ~11% EBITDA growth with margin compression, so Q2 needs to show correction
W2
European step-down subsidiary losses (Illichman Castalloy) — currently the main reason consolidated PAT (₹11.45 Cr) trails standalone (₹17.66 Cr); watch for narrowing
W3
New ₹125.5 Cr die-casting plant commissioning and ramp-up within the ₹130-150 Cr FY27 capex envelope
Figures in Lakhs converted to Cr. No exceptional item this quarter vs a ₹2.57 Cr one-off legal-settlement expense in the Jun-25 base (both statements), which flatters raw YoY PAT growth; consolidated PAT (₹11.45 Cr) trails standalone (₹17.66 Cr) because loss-making European step-down subsidiaries (Illichman Castalloy GmbH/SRO) drag the group number down; this filing's own Jun-25 comparative column (rev ₹419.11 Cr/PAT ₹9.31 Cr) differs slightly from our DB-tracked base (₹417.95 Cr/₹8.81 Cr) — YoY math below uses the filing's own column.
₹8,450 Crore Order Book Meets a ₹9.4% Margin
Alicon delivered record revenue (+38% YoY) and an order book worth ₹8,450 crore over six years. The street marked it down 2.95% on day 1 anyway. The gap between the order pipeline and the margin squeeze is where the real risk lives.
₹578 Cr
+38.3% YoY, +16.8% QoQ; real volume growth +17.5% (ex-aluminum)
9.4%
vs 11–12% prior; compressed despite cost recovery claims
₹11.4 Cr
+29.8% YoY; NPM 2.0% (lag vs revenue growth suggests tax/D&A burden)
₹8,450 Cr
6-year executable; ₹450 Cr + ₹850 Cr booked Q1
The quarter presents a classic earnings illusion. Revenue hit a record ₹578 crore (+38.3% YoY), and management raised FY27 growth guidance to 12–15% volume-adjusted. But the street marked it down 2.95% on day 1 anyway. Why? Because profit growth (+29.8% PAT) lagged revenue growth (+38.3%), operating margins compressed to 9.4% from 11–12%, and the real story sits between the headline and the guidance: Alicon is growing volume aggressively in a strong market, but structural margin improvement remains unproven. The ₹8,450-crore order book is material and real. The question is whether execution on complex programs and cost recovery will turn it into returns.
The margin squeeze: inflation vs. recovery
Reported revenue of ₹578 crore includes aluminum pass-through at list price: inflation-adjusted real volume growth was 17.5%, solid but not exceptional. Operating profit landed at 9.4%, down sharply from 11–12% in prior quarters. Management's narrative: aluminum is fully hedged at real-time pricing (effective April 1); labor and energy cost recovery is 'progressing in customer discussions,' with 'some approvals secured, others in flight.' The forensics of Q1 suggest the lag is real. Adjusted OPM, excluding aluminum, was roughly 11.4%—essentially flat YoY despite value-addition growth of +17.6%. That's not margin expansion; it's margin defense while inflation is being absorbed on both sides of the invoice.
We cannot simply rely on the price increases to protect the margins. We have to become structurally more efficient.
This statement—not the order book, not the guidance—is the quarter's honest note. Management is telegraphing that pricing power is limited and that profitability is contingent on operational discipline and mix-shift. That's a meaningful pullback from any aspiration of achieving the prior 14–15% EBITDA-margin target on pricing alone.
Real growth 17.5% after adjusting material inflation
Revenue +38.3% reported; aluminum accounts for ~20pp; 17.5% underlying volume growth is supported by tonnage data (9,124 tons +1% YoY) and mix-shift drivers (PV, hybrid, complex parts).
Supported
Strong profitability growth despite input cost volatility
PAT +29.8% YoY is healthy in isolation. But OPM compressed to 9.4% from 11–12%, and adjusted OPM (ex-aluminum) is flat YoY at ~11.4%. NPM 2.0% vs 9.5% EBITDA indicates ₹7+ crore in tax/D&A/working-capital drag not addressed.
Overstated
Order book ₹8,450 Cr executable with clear program visibility
Recent wins ₹450 Cr (5-yr, mixed programs) + ₹850 Cr (2 large OEMs, 5-yr) are real and booked. Over 6 years, ~₹1.4K crore in new-order revenue is annualized. But visibility and execution credibility are distinct.
Supported in aggregate; execution risk material
JLR e-Axle program ramping toward 600 sets/week with significant margin upside
JLR currently marginal in Q1 (600 sets/wk is the production target by Q3 calendar). SOP was delayed due to 2–3 year development cycles (vs 6–12 month standard); this compressed margins and delayed returns on earlier capex. When JLR peaks Q3, Q4 could show accretion, but timing is uncertain.
Supported in future; credibility gap in present
European recovery from Q4 FY27 onward; new programs under development
Currently 150–200 tons (~2% consolidated). Legacy programs ended Q1. New e-Axle program from large OEM is SOP Q4 FY27 (expected). This is a recovery assumption, not a near-term driver. Prior European guidance (Q2–Q3 recovery) materially missed.
Partial; timing risk high
Non-automotive diversification (HVAC, tractor, defence) building scale by end FY27
Non-auto is currently 2% of order book, down from a 25% prior aspiration. Team hired 7–8 months ago; early wins (HVAC data center, tractor, defence RFQs) exist. CEO expects 'positive change by end of FY27' but acknowledged it won't reach aspiration targets.
Hedged; scale unproven
What changed on this call
FY27 volume growth guidance raised to 12–15% (from prior 8–10%)
Large customer wins booked: ₹450 Cr + ₹850 Cr (strategic shift to PV/CV complexity)
Non-auto aspiration downgraded to 2% order book (from 25% revenue target)
European recovery timeline extended to Q4 FY27 (vs prior Q2–Q3)
Margin guidance conservatized: 'at least 1% improvement' (vs prior 1.5% aspiration)
Strategy reframed as ICE/hybrid focus (faster cycles) vs EV (2–3 year development)
The bull-bear ledger
Record revenue and executable order book (₹8,450 Cr over 6 years) anchor structural growth
Hybrid moat: single-source supplier to India's largest hybrid OEM (1M cylinders/year)
Market tailwinds strong: PV +11.3% Q1, hybrid +25–30% CAGR, CV +19.5%
Capacity >90% full; order-backed capex (Shikrapur ₹125 Cr → ₹500 Cr revenue, 4–5 years)
Reported profit lagged revenue growth (+29.8% vs +38.3%); margin compression visible and material
Operating margin 9.4% vs 11–12% prior; cost recovery only partial, timeline uncertain
ROCE structurally low at 10.7%; capex payback 3–4 years; if ROI disappoints, returns stay below WACC
Execution track record mixed: EV delays 2–3 years (vs 6–12 months standard), non-auto aspiration collapsed 25% → 2%
JLR marginal in Q1 despite 2–3 year development; European programs soft; timing risk material
Margin aspiration 14–15% with no timeline; credibility strained by Q1 compression and prior guidance misses
How the street is positioned
The day-1 reaction: Alicon announced Q1 results with a pre-result close of ₹741.35. The stock fell 2.95% the following day (down to ~₹719), with delivery of 63.2% — a modest but meaningful selloff that suggests the street saw the headline revenue but discounted the margin story. This is not a 'beat and pop' result; it's a 'beat on volume, miss on profitability quality' reaction. The day-1 move reflects justified skepticism: order book is real, but margin bridge is unproven.
Valuation and drawdown: At ₹725.1 (as of 2026-08-17), Alicon is trading -29.05% off its all-time high of ₹1,022 and +25.02% off its 52-week low of ₹580. The stock sits below its 200-day SMA of ₹738.33 but above its 20-day and 50-day SMAs (₹697.09, ₹665.83), suggesting a consolidation phase after a significant sell-off. The ATH-to-now drop of nearly 30% is steep; it likely reflects both market-wide correction and company-specific skepticism about margin durability.
Ownership and flows: FII holding is minimal at 0.20%, unchanged QoQ. DII trimmed 91 basis points QoQ to 10.62% — a modest but notable reduction, suggesting institutional lightness. Promoter stake remains stable at 53.79% (-22 bps QoQ, de minimis). This is a promoter-controlled, retail-heavy stock with minimal institutional conviction. The DII trim into a quarter of strong volume growth is telling: large domestic institutions are not convinced by the order book without proof of margin recovery.
The street's implicit thesis: The market is pricing in execution risk (JLR, Shikrapur, European ramp) + margin-recovery uncertainty at a significant discount to order-book optionality. If Alicon could credibly demonstrate that the Q1 margin squeeze is temporary and Q2–Q3 brings cost-recovery approvals + JLR ramp, the stock likely re-rates higher. But the day-1 selloff into volume-growth headlines and the DII trim into strength suggest the street is not yet convinced. The next catalyst is Q2 cost recovery and Q3 JLR inflection data.
The debate
The honest read: Alicon is capturing market share in a strong cycle (PV +11%, hybrid +25–30% CAGR) with a credible, booked order pipeline (₹8,450 crore). Volume discipline is evident: Q1 real growth of +17.5% ex-inflation is good execution. But structural margin improvement is unproven. Q1 margin compression (9.4% from 11–12%) and profit-growth lag (29.8% PAT vs 38.3% revenue) are red flags that cost recovery and pricing discipline are weaker than the 'reset-refocus' narrative suggests. The capex story (Shikrapur, automation) is real, but ROI is unproven: ROCE remains 10.7% and the target of 15% is aspirational. The stock's -29% drawdown from ATH and the day-1 -2.95% selloff into volume headlines are justified: this is optionality priced, not returns priced. Execution, not order pipeline, will determine re-rating. Near-term catalysts (Q2 cost recovery, Q3 JLR ramp, Shikrapur SOP March 2027) are the tests.
Margin recovery unproven; cost-recovery lag compounds
HighQ1 OPM 9.4% vs 11–12% prior; adjusted OPM (ex-aluminum) flat YoY at ~11.4%. If labor/energy customer approvals slip, margin aspiration (14–15%) becomes unachievable. Equity thesis depends entirely on mix-shift + automation delivering incremental margin; neither is yet visible.
Program SOP delays and development burn
HighJLR e-Axle took 2–3 years development (vs 6–12 months standard), is still marginal Q1, and is ramping Q3. European programs under development (SOP Q4 FY27). Tractor and HVAC are first-time wins. Each SOP delay or miss compresses capex ROI and delays ROCE recovery. Development burn of ₹3–5 crore/quarter masks underlying operational efficiency.
ROCE structural pressure; capex ROI unproven
MediumPrior ROCE 10.7% vs cost of capital; target 15% requires mix-shift + automation. If capex on Shikrapur, automation, or European expansion fails to drive ROI, returns stay below WACC. Payback periods of 3–4 years are long; margin compression extends payback further.
Competitive foundry capacity +3x in India
MediumAluminum casting capacity expansion and commodity 2-wheeler casting shift margin risk. Alicon's shift to complex/machined products (PV, hybrid, EV, e-Axle) is defensive, but tech moat may erode as competitors develop capabilities. Pricing power in 2-wheeler already collapsed; 4-wheeler/hybrid may follow if competitive intensity rises.
European operations underutilized; recovery timing uncertain
MediumCurrently 150–200 tons (~2% consolidated). Legacy programs ended Q1. New programs SOP Q4 FY27 expected but timing is uncertain. Capacity drag on consolidated margin until utilization improves. Prior European guidance (Q2–Q3 recovery) was materially missed; credibility gap remains.
Non-automotive diversification fails to scale
LowNon-auto 2% of order book vs 25% prior aspiration. Team hired 7–8 months ago; expecting 'positive change by end FY27' but far short of targets. If scale remains low, company stays 98% automotive-exposed. Reduces earnings resilience in a downturn.
Prior guidance misses erode management credibility
LowEV program delays (2–3 years), non-auto failure (25% → 2%), European misses (Q2–Q3 recovery → Q4). Management acknowledged these but defended with 'industry-norm' timelines. Each miss increases market skepticism about margin aspirations and capex payback claims.
1 · Q2 cost-recovery approvals and margin trajectory
The key test. Has labor/energy cost recovery closed with customers? Is OPM recovering toward 11–12%, or stuck at 9–10%? If stuck, the margin-recovery thesis deteriorates and price target needs to reset lower. If recovering, the Q3 JLR ramp becomes the next inflection. Watch the CFO's commentary on 'approvals in flight' and expected timing.
2 · Q3 JLR production ramp and margin data
JLR entering peak production (600 sets/week target, calendar Q3 = FY27 Q3). If JLR is high-margin (it should be, complex product for UK OEM), Q3 could show meaningful EBITDA accretion and re-rate sentiment. Conversely, if ramp is delayed or margins are lower than expected, ROCE recovery hypothesis fails. Watch for production volumes, delivery rates, and margin commentary.
3 · Shikrapur facility SOP (March 2027 target)
All capacity pre-booked; if on-time, validates execution track record on schedule and unblocks capex ROI narrative. Delay would be a major red flag (credibility hit, ROCE pressure). Watch announcement of possession (Sept 2026 target) and tooling/trial-run updates. Any hint of pushout should reset expectations.
4 · Non-auto scale by end FY27
Management promised 'positive change' in the non-auto pie by end FY27. Currently 2% of order book. If it stays <5%, the aspiration is quietly abandoned and the growth story is 98% automotive (concentration risk). If it reaches 5–10%, it begins to look like a real third pillar. Watch Q3 and Q4 non-auto order announcements and revenue contribution.
5 · FY28 capex announcement (location, timing, ROI)
For ₹1,600 crore revenue by 2030 target (2x from ~₹800 crore base), Alicon needs >₹150 crore/year capex beyond Shikrapur. CEO hinted 'very soon' but withheld details ('different part of country', no location/timeline). Timing and ROI clarity will reset valuation. Watch for press release or next earnings call. Vague or delayed disclosure suggests confidence issues internally.
Alicon proved in Q1 that it can execute volume in a strong market. Revenue hit ₹578 crore (record), real growth was +17.5% ex-inflation, and the ₹8,450-crore, six-year order book is material and executable. But the quarter also confirmed that structural margin expansion is harder than the 'reset-refocus-rebuild' narrative suggests. Operating margins compressed to 9.4% (from 11–12%), profit growth lagged revenue growth, and cost recovery is only partial. The street's -2.95% day-1 reaction and -29% drawdown from ATH reflect justified skepticism: this is an optionality story (order book, capex, program ramps) priced at a discount to demonstrated returns (margin improvement, ROCE recovery).
The stock trades at ₹725 with RSI 61 (neutral), above near-term SMAs but below the 200-day. Institutional ownership is light (FII 0.20%, DII 10.62% and trimming). The bull case depends entirely on execution: Q2 cost recovery, Q3 JLR ramp, Shikrapur SOP by March 2027, and European recovery by Q4. If these inflections land on time and drive margin accretion, re-rating to ₹900–₹1,000 is plausible. If they slip, the order book becomes inventory of optionality without return, and the stock re-tests ₹600. For now, it's a Hold at ₹725. Watch Q2 for cost-recovery data and Q3 for JLR. The number to track from here is operating margin — not the order book, but whether Alicon can turn ₹8,450 crore in orders into sustainable profitability on the income statement.
Record growth but margin squeezed; order book concrete, execution unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Prior FY26 guidance 8-10% growth; delivered 12-15% volume-adjusted. Prior aspiration non-auto 25% of revenue; delivered 2% of order book. Prior EV bet (e-Axle, JLR) underdelivered vs expected ramp.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong revenue momentum (+38% YoY) and order visibility (₹8.4K Cr backlog) offset by near-term margin compression (9.4% vs 11-12% prior) and unproven execution on complex programs (JLR marginal in Q1, European delayed). CEO strategy credible but track record on prior guidance (EV timelines, non-auto diversification) weak.
₹578 Cr
Revenue · +38.3% YoY₹11.4 Cr
Reported PAT · +29.8% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Real growth 17.5% after adjusting material inflation
METReported revenue +38.3% YoY; difference attributable to aluminum/alloy price passthrough aligns with management's inflation claim
Strong profitability growth despite input cost volatility
OVERSTATEDPAT +29.8% YoY (₹11.4 Cr), but OPM 9.4% vs prior ~11-12% range; adjusted OPM ~11.4% ex-aluminum, so real margin flat, not improved
Order book ₹8,450 Cr executable with clear program visibility
METRecent wins: ₹450 Cr (5-yr, mixed) + ₹850 Cr (2 large OEMs, 5-yr). JLR 600 sets/wk but marginal in Q1, peaking Q3 calendar. Execution risk material.
European recovery reversal from Q4 FY27 onwards
PartialCurrently 150-200 tons consolidated (2%); new e-Axle program under development. SOP timing dependent on customer program schedule; prior European guidance materially missed
Earnings quality
What changed since the last call
FY27 revenue growth guidance
UpgradePrior 8-10% (FY26 call); now 12-15% volume-adjusted. Q1 delivered 17.5% underlying (exceeds both). Upgrade driven by strong order wins (₹450 Cr + ₹850 Cr) and market tailwinds (PV record, hybrid +25-30% CAGR).
Customer wins and order book
Upgrade₹450 Cr (5-yr, auto/non-auto) + ₹850 Cr (2 large OEMs, 5-yr) booked in Q1. Prior quarters: incremental single-digit orders. JLR e-Axle, tractor (first-ever), HVAC data center wins represent strategic shifts.
European business trajectory
DowngradeQ1 softer than expected (legacy programs ended). Recovery now Q4 FY27 vs prior Q2-Q3 expectation. New programs under development; timing uncertain. 150-200 tons (~2% consolidated) currently.
Non-auto diversification progress
DowngradePrior aspiration: quarter of revenue from non-auto. Current: 2% of order book. Team hired 7-8 months ago; expects 'positive change by end FY27' but far short of prior targets.
Margin expansion scope
MaintainedPrior guidance: ~1.5% EBITDA expansion; now 'at least 1%' stated conservatively. Both anchored on cost recovery + internal productivity. Aspiration 14-15% long-term; timeline vague.
The Q&A
Analyst Ramesh (SJ Investments) pressed hard on prior order book misses (EV underdelivery, non-auto failure), ROCE (10.7% vs cost of capital), capex ROI payback. Management candid: acknowledged EV development timelines 2-3 yrs (vs standard 6-12 mo) derailed prior schedules; now prioritizing ICE/hybrid for quicker wins. Defended ROCE recovery via mix-shift and automation. Hedged on margin aspiration (14-15%) timeline; stated 'working aggressively' but no commitment.
Overseas performance & FY27 guidance — Raghunandhan N L, Nuvama Research
PartialEurope: 1-2 more quarters reduced, reversal Q4 FY27. FY27: 12-15% growth (volume-adjusted). Multi-year: similar rate; inorganic M&A to come (details withheld).
Margin recovery path — Raghunandhan N L, Nuvama Research
DodgedAt least 1% improvement expected FY27. Beyond that: 'difficult to give guidance' due to cost initiatives in flight. Progress dependent on execution.
Non-automotive traction — Avinash Nahata, Parami Financial
AnsweredTeam 7-8 months in; already won HVAC (data center, global expansion Q2-Q3 to Europe/Mexico), defence, tractor (first-ever, replaces cast iron). Survey shows 7-8 more parts + customers to tap; 'special project' status.
Volume slowdown risk — Bhavya Doshi, Sushil Finance
AnsweredNo slowdown seen; volatility to monitor. 12-15% clearly visible from order pipeline; no reason for step-down unless macro shifts.
New plant economics — Atharva Deshmukh, MM Capital
PartialSOP March 2027; all business pre-booked (no new order hunting). Capacity 3,000→7,000 tons. Further capacity announcements coming 'soon' (vague timing).
ROCE and capex returns — Riddhesh Gandhi, Discover Capital
DefensivePayback 3-4 yrs typical. JLR & legacy investments currently dragging ROCE; will 'turn around this year.' Prior 10.7% → targeting 15% with 'minor tweaks' visible. Mix shift to high-value products key.
Order book execution credibility — Ramesh, SJ Investments
AnsweredEV had 2-3 yr development cycles (Tier-1 + OEM dual validation), longer than standard 6-12 mo, derailed priors. Now focusing ICE/hybrid (faster cycles). Clear parts focus (cylinder heads, e-Axle) vs broad 'critical parts' bets.
Margin aspiration credibility — Ramesh, SJ Investments
Hedged'No reason to say not possible'; aspiration 14-15%. Timeline 'difficult to give'; working aggressively on structural profitability, not just price recovery.
Competitive pricing pressure — Ramesh, SJ Investments
AnsweredTech moat (e-Axle, complex parts) insulates from price competition. Tooling transfers happening (not commoditized). 2-wheeler inherently low-margin (high-vol); 4-wheeler high-margin (critical/complex). Intentionally de-prioritizing 2-wheeler.
Guidance
FY27 volume growth 12-15% (post-aluminum adjustment)
MediumRaised vs prior 8-10%. Anchored on Q1 17.5% delivery and visible order book (₹8.4K Cr). Assumes no macro downturn; volume-adjusted means inflation could re-add points if passthrough delayed.
Aluminum costs real-time passthrough (immediate); labor/energy recovery Q2-Q3
MediumAluminum tied to daily pricing effective April 1. Labor/energy in customer discussions; 'some approvals secured, others progressing'; expects resolution current quarter.
European recovery Q4 FY27; contribution increases thereafter
LowCurrently 150-200 tons (~2% consolidated). New programs SOP timing uncertain; prior European guidance materially underdelivered.
At least 1% EBITDA margin improvement in FY27
MediumQ1 reported 9.5% (aluminum-pressured). Prior year ~11-12% implied. Path: cost recovery + internal productivity + volume absorption. Conservative vs prior 1.5% aspiration.
Structural margin improvement via mix (higher value-add, machining expansion, automation)
MediumValue addition +17.6% Q1 signal. Machining 65-70% of PV tonnage (target higher). Capacity reallocation away from low-margin 2-wheeler underway.
Long-term aspiration 14-15% EBITDA margins (vs 11-12% prior era)
Low'No reason to say not possible' per CEO. Timeline vague ('working aggressively'). Dependent on mix-shift execution, automation ROI, competitive dynamics, customer negotiations.
FY27 capex ₹150 Cr (₹70 Cr Shikrapur, rest automation/maintenance existing plants)
HighQ1 ₹40 Cr on track. Phased over 2-3 years. Funded via internal accruals + borrowing. Paced to customer program demand.
Shikrapur facility ₹125 Cr investment generating ₹500 Cr annual revenue in 4-5 years (3,000→7,000 ton capacity)
MediumPossession Sept 1, 2026; SOP March 2027 target. All capacity pre-booked (no new order risk). Ramp dependent on customer program SOP schedules.
Further capacity investments announced 'very soon' for ₹1,600 Cr by 2030 revenue target (2x from ~₹800 Cr base)
LowCEO vague: 'different part of country,' no location/timing. For 50% revenue CAGR, significant capex beyond ₹125 Cr Shikrapur clearly required; specifics withheld.
Risks the call surfaced
Program execution & SOP delays
HighJLR e-Axle, European programs, tractor, data center HVAC all early-stage. Prior e-Axle took 2-3 yrs (vs 6-12 mo traditional). If SOP delays persist, revenue misses, capex ROI at risk, consolidated margin drag continues.
Margin recovery execution
MediumLabor, energy, logistics costs rising. Customer price recovery 'under discussion' with partial approvals. 2-wheeler commoditized (inherent low margins). If competitive foundry capacity (+3x) intensifies, pricing power erodes; margin aspiration 14-15% unachievable.
ROCE and capex payback
MediumPrior ROCE 10.7%; target 15% via mix-shift + automation. JLR, European ops currently dragging (investments in place, revenue lag). If programs don't ramp as planned, capex burn continues with deferred returns.
Non-automotive diversification failure
LowNon-auto 2% of order book (vs 25% prior aspiration). Dedicated team hired 7-8 months ago; expecting 'positive change by end FY27' but well below prior targets. If scale fails, company remains 98% automotive-exposed.
Management
Score 7/10. CEO articulate (Reset-Refocus-Rebuild framework clear). Transparent on cost inflation and execution challenges. Candid on margin guidance limits ('difficult to give'). Q&A showed ability to defend strategy under pressure. No evasion on core strategy; hedged on timelines and future capex detail (vague 'soon'). Mixed track record. Delivered 12-15% volume growth (vs 8-10% prior) = positive. Non-auto 2% vs 25% aspiration = major miss. EV development delays (2-3 yrs standard) = execution risk. Margin flat despite cost recovery headlines = creditable but not impressive. Overall: solid on core business, weak on diversification and complex programs.
1 · Q2-Q3 FY27
JLR ramps toward 600 sets/wk peak; new OEM programs enter production; customer cost-recovery approvals close
2 · Q4 FY27
Shikrapur facility SOP (March 2027 target); European programs ramp; 1% margin improvement begins to show
3 · FY28 H1
Non-auto (HVAC, tractor, defence) begins scaling from 2% baseline; second capacity investment announcement expected
CEO strategy credible but track record on prior guidance (EV timelines, non-auto diversification) weak.